<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><description>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 09 Mar 2021 20:23:33 +0800</pubDate><image><url>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</url><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>2021 年 2 月 CDE 药品审评报告</title><link>https://mp.weixin.qq.com/s/bnDJaoyITYpaBGSNwbQ2zA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZZWn5CVvRLQ6Js1B5EYTqvu2KAictyeL6P5KTIwgqcn5EuKficwP8RpSUJ04cmvY40phaIIOzau0ZzA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>丁香园 Insight 数据库]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:28:02 +0800</pubDate></item><item><title>继阿斯利康之后，罗氏 PD-L1 撤回了膀胱癌适应症</title><link>https://mp.weixin.qq.com/s/d8ZGuyoLzLyp7OlGu-4KNA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa0olysdu2fMUQaB7joHPicgs1kpGKicurT56LzjfLJPB1BDDtxkmTrgfJENa44l5SxgYurjHFNeNBw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:28:02 +0800</pubDate></item><item><title>海正药业高级副总裁徐晓艳辞职</title><link>https://mp.weixin.qq.com/s/L0c1Wg8c5HoQ59NIAABWQQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa0olysdu2fMUQaB7joHPicgWuf2DibZ8BILzYuwGxiacpMGZ1AjdKre2hAPKYZX6SXytZDAmLReC1wA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药企高管离职季]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:28:02 +0800</pubDate></item><item><title>境外已上市境内未上市化药药学研究技术要求（试行）来了</title><link>https://mp.weixin.qq.com/s/OmJ5CNRw9rDA7WmBFxqMhw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa0olysdu2fMUQaB7joHPicgexXSoI2L06xceicpz2vLKD7jnOuWym1t6PGSYWREeFsYQ42lHS3KMyg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>附全文下载]]></content:encoded><pubDate>Tue, 09 Mar 2021 18:28:02 +0800</pubDate></item><item><title>符合第 5 批集采品种已达 86 个，胰岛素或启动专项采购！(附 Excel 下载)</title><link>https://mp.weixin.qq.com/s/7tTcBzw_mQQy__YhLBC4Zw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZY9ho3cpXQibatNR4F4EJTcJ6DRvmyzRkb5kgNScWkicR4KwibMLoEfuOSDHwfwEBcTx2lF3Sxh9icp9A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>丁香园 Insight 数据库]]></content:encoded><pubDate>Mon, 08 Mar 2021 16:29:31 +0800</pubDate></item><item><title>首仿！正大天晴「仑伐替尼」即将获批</title><link>https://mp.weixin.qq.com/s/qm1eVPbDv71e8vyFKJbrNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZY9ho3cpXQibatNR4F4EJTcJiaYt8Ig4mV8aeHwItLsE0laQL5Vic5xMOfhjFxN8djO3GeW4QktcFuXQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 08 Mar 2021 16:29:31 +0800</pubDate></item><item><title>针对二/三线 NSCLC，百济神州 PD-1 第 6 个适应症报上市！</title><link>https://mp.weixin.qq.com/s/Ve_Ew7b3Cyu0pwGNr0mpGw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZY9ho3cpXQibatNR4F4EJTcJp13tcEpVsRSXPqyRXCLdvpBR4sboSY3F7DVwJPelPF3bZ83WSv8kgQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 08 Mar 2021 16:29:31 +0800</pubDate></item><item><title>终版议程大公开|IDC2021化学创新药研发与分析论坛报名通道即将关闭</title><link>https://mp.weixin.qq.com/s/tu1FdxdlSS-kWWkcZTotdA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/9NKpZFWnL9e7j3WVRRmenLHHLFqK9Bial3SS4sjCaic2ROpSjcicNOictR1QcNnevQicJEGq2oJsIH5waNdwIAHdLKg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>终版议程大公开|IDC2021化学创新药研发与分析论坛报名通道即将关闭]]></content:encoded><pubDate>Mon, 08 Mar 2021 16:29:31 +0800</pubDate></item><item><title>都是免疫治疗，PD-1 和 PD-L1 抑制剂到底有什么区别？</title><link>https://mp.weixin.qq.com/s/-89LWS4Dm4XTQFV-G755Bg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYB6wZEkfNw28uMpzSWHEYgbg3JcY8f8AFTmke5Jwzc4PgCJGtIicYdEMzib0NGUtlr5qgYEGmuYWlA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一文梳理PD-1/PD-L1抑制剂作用机制、疗效和不良事件差异]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:24:15 +0800</pubDate></item><item><title>第 35 批「通过一致性评价」名单来了</title><link>https://mp.weixin.qq.com/s/ka2F4vB7S7y6g6pIX2m_mw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYWmRmAzr1kqOfodGWD10U8Op0gIc1fpWxlAy9RHAmaxy0jpMTDyq8lHj1P9coLr5pLdsLwOxtMJA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight出品，最新一致性评价报告来了~]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:05:14 +0800</pubDate></item><item><title>3.4 亿打水漂，百奥泰终止 3 个新药项目</title><link>https://mp.weixin.qq.com/s/NrsVmNfSwRtMxe7j7LpRyw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZZWn5CVvRLQ6Js1B5EYTqvukF6bkPcPAatwld8BekIq9pD2sf5YKaiaAmgGV697xSHWbc66S5146hA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:05:14 +0800</pubDate></item><item><title>安进 19 亿美元囊获胃癌一线疗法，国内再鼎已启动 III 期临床</title><link>https://mp.weixin.qq.com/s/lksWHFLikHG35MRG0xUcwg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZZWn5CVvRLQ6Js1B5EYTqvuGibhfXhgicAnlk852SrmBbgM3icjppkamNRnZgOQq8PqmWf2mRtZCLn7g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:05:14 +0800</pubDate></item><item><title>降糖新疗法！礼来 GLP-1/GIPR 双重激动剂 III 期头对头司美鲁肽成功</title><link>https://mp.weixin.qq.com/s/62vxvhV_HFzohcZHWXwI0A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZZWn5CVvRLQ6Js1B5EYTqvul4I4VBcDqJgBalk2wXxG43vA1o6HGG5wmCicMdeBKBtc9IPuIb0uSzw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:05:14 +0800</pubDate></item><item><title>君实生物 1 类新药临床申请获受理，拟用于高尿酸血症及痛风</title><link>https://mp.weixin.qq.com/s/XWQNn7A0rzW7v4Js5SWm2A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZZWn5CVvRLQ6Js1B5EYTqvuANXvic4DUBwzLUJcRE4Uhm9s6orLia4yIBXKT4ncVqwBfa31ePn6es3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:05:14 +0800</pubDate></item><item><title>荣昌生物 1 类新药「泰它西普」即将获批</title><link>https://mp.weixin.qq.com/s/Qdo21GhutkXaZh0sj5WbZA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8GoqrZFSlPAqjVafmuqqyjCaMWhppOmZhWXULJ3iaeag8iaJk3kTBIJag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>贝达药业三代 EGFR 抑制剂报上市，四代在路上，肺癌靶向药组合发力！</title><link>https://mp.weixin.qq.com/s/K4AeW763zy7t6Sb_DhgRxA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8l7MB670MRkm84HbLZlPAIq17s2eicSTAuAh7vOmM0icb5l9gUxjbBa2w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>斑秃患者福音！礼来 JAK 抑制剂 3 期临床达到主要终点</title><link>https://mp.weixin.qq.com/s/kqNbYRqaiXKPwlaO_a4Ynw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8XeL0c1sbYQtJwm2pl9ffAD7nLDMRuCCDiavVls7iaGCMy0EKp2y9EF6A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>首个国产 PD-1 在 FDA 递交上市申请！来自君实生物</title><link>https://mp.weixin.qq.com/s/7HuJhALhuJQnEbPXPPmBww</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8iasqcMOPEQKouPS2mUo96uUicCN3yzezfZ0DGrsYUrbCsTDibyAgxomJw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>牵手阿斯利康，君实生物能否完成逆袭？</title><link>https://mp.weixin.qq.com/s/nZSlEM-Hydq9oanjQ8jQAQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa4WQ2cGuCHluPL5ibt7tfv4J6wsgV5OH4kBpjbNQbsgSFBUicFdmEYwd69NOSz7g0EDXeFmPWGEN3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Wed, 03 Mar 2021 16:15:10 +0800</pubDate></item><item><title>第 2 款国产三代 EGFR 抑制剂！艾力斯医药「伏美替尼」获批上市</title><link>https://mp.weixin.qq.com/s/_j57BLYbpbCAhRaoNS_-nQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa4WQ2cGuCHluPL5ibt7tfv42j9nYYtpjJLvqZ1icsTacQ7SNFnm3EicoqeDGEadxpkJeicjPhzJesXQw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Wed, 03 Mar 2021 16:15:10 +0800</pubDate></item></channel></rss>